NEW YORK (GenomeWeb) ─ Genomic Health reported after the close of the market Tuesday that its fourth quarter revenues were up a fraction of 1 percent year over year, falling short of the consensus Wall Street estimate.

For the three months ended Dec. 31, Genomic Health had revenues of $69.1 million compared to $68.8 million in the same period last year. On average, analysts had expected revenues of $72 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.